QIMING U.S. VENTURES MANAGEMENT, LLC Holdings

QIMING U.S. VENTURES MANAGEMENT, LLC is an investment fund managing more than 68.85M US dollars. The largest holdings include Ventyx Biosciences, Icosavax and HilleVax.

$68.84M

portfolio value

+3.50%

quarter

QIMING U.S. VENTURES MANAGEMENT, LLC portfolio changes

QIMING U.S. VENTURES MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 37.85% Portfolio value: 26.05M Avg. open price: N/A Current price: $28.98 P/L: N/A Sold -18.01% shares Q3 2022	share	37.85%	26.05M	N/A	$28.98	N/A	Sold -18.01% shares Q3 2022
Biotechnology Icosavax, Inc. Portfolio share: 16.11% Portfolio value: 11.09M Avg. open price: N/A Current price: $3.28 P/L: N/A N/A Q4 2021	share	16.11%	11.09M	N/A	$3.28	N/A	N/A Q4 2021
Biotechnology HilleVax, Inc. Portfolio share: 13.87% Portfolio value: 9.55M Avg. open price: N/A Current price: $19.05 P/L: N/A N/A Q2 2022	share	13.87%	9.55M	N/A	$19.05	N/A	N/A Q2 2022
Biotechnology Talaris Therapeutics, Inc. Portfolio share: 11.20% Portfolio value: 7.71M Avg. open price: N/A Current price: $1.45 P/L: N/A N/A Q4 2021	share	11.20%	7.71M	N/A	$1.45	N/A	N/A Q4 2021
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 10.36% Portfolio value: 7.13M Avg. open price: N/A Current price: $7.43 P/L: N/A N/A Q4 2021	share	10.36%	7.13M	N/A	$7.43	N/A	N/A Q4 2021
Biotechnology Jasper Therapeutics, Inc. Portfolio share: 6.71% Portfolio value: 4.61M Avg. open price: N/A Current price: $0.61 P/L: N/A N/A Q4 2021	share	6.71%	4.61M	N/A	$0.61	N/A	N/A Q4 2021
Biotechnology Elevation Oncology, Inc. Portfolio share: 3.89% Portfolio value: 2.67M Avg. open price: N/A Current price: $0.91 P/L: N/A N/A Q4 2021	share	3.89%	2.67M	N/A	$0.91	N/A	N/A Q4 2021

Showing TOP 7 QIMING U.S. VENTURES MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of QIMING U.S. VENTURES MANAGEMENT, LLC?

The biggest position of the QIMING U.S. VENTURES MANAGEMENT, LLC is Ventyx Biosciences, Inc. (VTYX) with 37.85% portfolio share worth of 26.06M US dollars.

Top 5 QIMING U.S. VENTURES MANAGEMENT's holdings represent 89.4% of the portfolio:

Ventyx Biosciences, Inc. (VTYX) – 37.85%
Icosavax, Inc. (ICVX) – 16.11%
HilleVax, Inc. (HLVX) – 13.87%
Talaris Therapeutics, Inc. (TALS) – 11.2%
Kezar Life Sciences, Inc. (KZR) – 10.36%

Who is the portfolio manager of QIMING U.S. VENTURES MANAGEMENT, LLC?

The portfolio manager of the QIMING U.S. VENTURES MANAGEMENT, LLC is .

What is the total asset value of the QIMING U.S. VENTURES MANAGEMENT, LLC portfolio?

QIMING U.S. VENTURES MANAGEMENT, LLC total asset value (portfolio value) is 68.85M US dollars.

Who is ?

is the portfolio manager of the QIMING U.S. VENTURES MANAGEMENT, LLC.

What is (QIMING U.S. VENTURES MANAGEMENT, LLC) fund performance?

QIMING U.S. VENTURES MANAGEMENT's quarterly performance is +3.50%, annualy 0.00%.

What is the QIMING U.S. VENTURES MANAGEMENT, LLC CIK?

QIMING U.S. VENTURES MANAGEMENT's Central Index Key is 0001909617 .